Dronedarone for the treatment of atrial fibrillation and atrial flutter: Approval and efficacy

Vascular Health and Risk Management

Volumn 6, Issue 1, 2010, Pages 517-523

  Wolbrette, Deborah ^a   Gonzalez, Mario ^a   Samii, Soraya ^a   Banchs, Javier ^a   Penny Peterson, Erica ^a   Naccarelli, Gerald ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Amiodarone; Atrial fibrillation; Atrial flutter; Dronedarone

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRONEDARONE; PLACEBO; SIMVASTATIN; VERAPAMIL; ANTIARRHYTHMIC AGENT; DRUG DERIVATIVE;

BRADYCARDIA; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DIARRHEA; DRUG ABSORPTION; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART EJECTION FRACTION; HUMAN; NAUSEA; QT INTERVAL; QT PROLONGATION; RECOMMENDED DRUG DOSE; REVIEW; RISK REDUCTION; SIDE EFFECT; SINUS RHYTHM; SLEEP DISORDER; THYROID DISEASE; TREATMENT DURATION; TREATMENT OUTCOME; TREMOR; DRUG EFFECT; HEART STROKE VOLUME; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTMARKETING SURVEILLANCE;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; DRUG APPROVAL; HUMANS; PRODUCT SURVEILLANCE, POSTMARKETING; STROKE VOLUME;

EID: 79952048655     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006; 114:119-125.
2. Friberg J, Buch P, Scharling H, et al. Rising rates of hospital admissions for atrial fibrillation. Epidemiology. 2003;14:666-672.
3. AFFIRM Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators. N Engl J Med. 2002;347:1825-1833.
4. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Circulation. 2004;109:1509-1513.
5. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2006; 48:854-906.
6. Wegener FT, Ehrlich JR, Hohnloser SH. Dronedarone: An emerging agent with rhythm- and rate-controlling effects. J Cardiovasc Electrophysiol. 2006;17 Suppl 2: S17-S20.
7. Hodeige D, Heyndrickx JP, Chatelain P, Manning A. SR33589, a new amiodarone-like anti-arrhythmic agent: Anti-adrenoceptor activity in anesthetized and conscious dogs. Eur J Pharmacol. 1995;279:25-32.
8. Lalavee N, Nargeot J, Barrere-Lemaire S, Gautier P, Richard S. Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes. J Cardiovasc Electrophysiol. 2003;14: 885-890.
9. Guillemare E, Marion A, Nisato D, Gautier P. Inhibitory effects of dronedarone on muscarinic K+ current in guinea pig atrial cells. J Cardiovasc Pharmacol. 2000;130:1315-1320.
10. Zareba KM. Dronedarone: A new antiarrhythmic agent. Drugs Today (Barc). 2006;42:75-86.
11. Patel C, Yan GX, Kowey PR. New drugs and technology: Dronedarone. Circulation. 2009;120:636-644.
12. Tschuppert Y, Buclin T, Rothuizen LE, et al. Effect of dronedarone on renal function in healthy subjects. Br J Clin Pharmacol. 2007; 64:785-791.
13. Touboul P, Brugada J, Capucci A, Crÿns, HJ, Edvardsson N, Hohnloser SH. Dronedarone for prevention of atrial fibrillation: A dose-ranging study. Eur Heart J. 2003;24:1481-1487.
14. Singh BN, Connolly SJ, Crÿns, HJ, et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med. 2007;357: 987-999.
15. Davy JM, Herold M, Hoglund C, et al. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The efficacy and safety of dronedarone for the control of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J. 2008;156:527-529.
16. Køber L, Torp-Pedersen C, McMurray JJ, et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med. 2008;358: 2678-2687.
17. Zimetbaum PJ. Dronedarone for atrial fibrillation - an odyssey. N Engl J Med. 2009;360:1811-1813.
18. Hohnloser SH, Crÿns, HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med. 2009;360: 668-678.
19. Connolly SJ, Crÿns, HJ, Torp-Pedersen C, et al. Analysis of stroke in ATHENA: A placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Circulation. 2009;120:1174-1180.
20. Sherman DG, Kim SG, Boop BS, et al. Occurrence and stroke characteristics of stroke events in Atrial Fibrillation Follow-Up Investigation of sinus Rhythm Management (AFFIRM) study. Arch Intern Med. 2005;165:1185-1191.
21. Heuzey JY, De Ferrari GM, Radzik D, et al. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: The DIONYSOS study. J Cardiovasc Electrophysiol. 2010 Apr 6. [Epub ahead of print].
22. Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol. 2009;54:1089-1095.